AzTrials
AzTrials

Condition

Mild Cognitive Impairment Clinical Trials

Studies of mild cognitive impairment, matched by condition name and medical subject headings. Start with those open to enrolment.

2,038 registered studies

In numbers

Open to volunteers
541
Active
630
With results posted
268
All registered
2,038

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 541
  • Cognitive Enhancement, Subjective Cognitive Decline (SCD)

    The Efficacy of an IADL-based Non-immersive Virtual Reality Training Program to Enhance ADL Performance and Cognitive Function for Persons at Risk of Dementia

    • Recruiting
    • Age: 50 years and older
    • Lifestyle or therapy programme

    The goal of this clinical trial is to learn if a touchscreen-based virtual reality (VR) training program that simulates everyday life tasks works to improve daily living skills and thinking abilities in adults aged 50 and older…

    Conditions
    Cognitive Enhancement, Subjective Cognitive Decline (SCD), Mild Cognitive Impairmen
    Trial name
    NCT07895979
    Testing
    Daily Life VR Training, Non-Conditional Game VR Training, Traditional Cognitive Training
    Where
    Taiwan
    Volunteers
    216 people, healthy volunteers welcome
    Sponsor
    National Taiwan University Hospital
    Can I take part? NCT07895979
  • Preclinical Alzheimer's Disease, Alzheimer Disease

    Alzheimer's Tau Platform: Master Protocol

    • Recruiting
    • Age: 50 to 80 years
    • Phase 2

    The goal of the Alzheimer's Tau Platform (ATP) is to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with the anti-amyloid monoclonal antibody, donanemab, in adults aged 50-80 with late…

    Conditions
    Preclinical Alzheimer's Disease, Alzheimer Disease, Prodromal Alzheimer's Disease
    Trial name
    ATP (NCT06957418)
    Testing
    AADvac1, Tau2
    Where
    7 sites in United States
    Volunteers
    900 people
    Sponsor
    Paul S. Aisen
    Can I take part? ATP
  • Alzheimer s Disease, Mild Cognitive Impairment

    PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

    • Recruiting
    • Age: 50 to 100 years
    • Phase 1

    Background: About 5 million adults in the United States have age-related brain disorders. These include Alzheimer disease (AD), mild cognitive impairment (MCI), and other dementias.

    Conditions
    Alzheimer s Disease, Mild Cognitive Impairment, Healthy
    Trial name
    NCT07169630
    Testing
    18F-PF974, 18F-florbetaben
    Where
    United States
    Volunteers
    90 people, healthy volunteers welcome
    Sponsor
    National Institute of Mental Health (NIMH)
    Can I take part? NCT07169630
  • Dementia, Alzheimer Dementia (AD)

    Fuzhou Aging Brain Health Initiative

    • Recruiting
    • Age: 55 to 90 years
    • Observational study

    The goal of this observational study is to learn about the pathophysiological characterization and evolutionary patterns of Alzheimer's disease (AD) in older adults in Fujian Province, China.

    Conditions
    Dementia, Alzheimer Dementia (AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
    Trial name
    FAITH (NCT07891429)
    Testing
    Fluids biomarker and neuroimaging of AD diagnosis
    Where
    4 sites in China
    Volunteers
    3,000 people, healthy volunteers welcome
    Sponsor
    Fujian Medical University Union Hospital
    Can I take part? FAITH
  • Dementia (Diagnosis), Mild Cognitive Impairment

    Choose Myself (Before) Losing Myself

    • Recruiting
    • Age: 18 years and older

    The purpose of this study is to see if an educational interactive booklet about how dementia progresses throughout a person's life can be a helpful tool for patients to think about future decisions that might need to be made…

    Conditions
    Dementia (Diagnosis), Mild Cognitive Impairment, Alzheimer's Disease Dementia, Alzheimer's Disease
    Trial name
    CYOA (NCT07846566)
    Testing
    CYOA booklet
    Where
    United States
    Volunteers
    25 people
    Sponsor
    The Cleveland Clinic
    Can I take part? CYOA
  • Mild Cognitive Impairment, Alzheimer's Disease

    Use of Wearables for Identifying Factors Associated With Mild Cognitive Impairment and Early-Stage Alzheimer's Disease

    • Recruiting
    • Age: 65 years and older
    • Observational study

    Cognitive decline affects millions of older adults worldwide and has a profound impact on individuals, families, and healthcare systems.

    Conditions
    Mild Cognitive Impairment, Alzheimer's Disease, Alzheimer's Disease Dementia
    Trial name
    NCT07391436
    Where
    Brazil
    Volunteers
    150 people, healthy volunteers welcome
    Sponsor
    Getúlio Vargas University Hospital
    Can I take part? NCT07391436
  • Alzheimer, Cognitive Unimpaired

    Brain Heath Service for Prevention of AD

    • Enrolling by invitation
    • Age: 55 to 80 years
    • Lifestyle or therapy programme

    The aim of the program to serve as a prototype for future preventive program for AD in the region. The program will recruit elderly participants.

    Conditions
    Alzheimer, Cognitive Unimpaired, Mild Cognitive Impairment
    Trial name
    BEAT AD (NCT07834528)
    Testing
    medical referral and/or educational programs
    Where
    China
    Volunteers
    4,000 people, healthy volunteers welcome
    Sponsor
    Chinese University of Hong Kong
    Can I take part? BEAT AD
  • Mild Cognitive Impairment

    Cognitive Effects and Potential Mechanisms of TBS in Subjects With MCI

    • Enrolling by invitation
    • Age: 50 to 90 years
    • Medical device

    This study aims to examine the effects and potential mechanisms of theta-burst stimulation (TBS) on cognitive function in individuals with mild cognitive impairment (MCI).

    Trial name
    NCT05448768
    Testing
    TBS for Amyloid-positive MCI, TBS for Amyloid-negative MCI
    Where
    Taiwan
    Volunteers
    80 people
    Sponsor
    Chang Gung Memorial Hospital
    Can I take part? NCT05448768
  • Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI)

    InRAD Observational Study

    • Recruiting
    • Age: 18 years and older
    • Observational study

    The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across…

    Conditions
    Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), Non-Alzheimer Degenerative Dementia
    Trial name
    InRAD (NCT07213700)
    Testing
    None, this is a non-interventional observational study
    Where
    23 sites in Australia, Austria and 15 more
    Volunteers
    50,000 people
    Sponsor
    Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
    Can I take part? InRAD
  • Mild Cognitive Impairment (MCI), Mild Cognitive Impairment (MCI) Amnestic

    Deep Brain Stimulation Guided by Brain Mapping to Treat Cognitive Impairment

    • Not yet recruiting
    • Age: 60 to 85 years
    • Medical device

    This trial is a 12-month safety and feasibility study, enrolling up to six participants. These participants will serve as their own controls, structured in multiple parts that follow an initial short-term stereo…

    Conditions
    Mild Cognitive Impairment (MCI), Mild Cognitive Impairment (MCI) Amnestic, Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease, Memory Deficit
    Trial name
    NCT07887737
    Testing
    Abbott St Jude Medical Infinity™
    Volunteers
    6 people
    Sponsor
    University of Texas Southwestern Medical Center
    Can I take part? NCT07887737

Completed, with results posted

All 233
  • Alzheimer Disease

    Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy

    • Completed
    • Age: 60 years and older
    • Lifestyle or therapy programme
    • Results posted

    The objective of this study is to demonstrate the impact of a socially assistive robot system on reducing apathy among cognitively impaired older adults residing in long term care facilities.

    Trial name
    NCT05178992
    Testing
    Socially Assistive Robot Activity
    Where
    United States
    Volunteers
    142 people
    Sponsor
    Vanderbilt University
    Can I take part? NCT05178992
  • Mild Cognitive Impairment, Adherence, Patient

    MI-CBT Adherence Program for Lifestyle Interventions in Older Adults

    • Completed
    • Age: 60 to 85 years
    • Lifestyle or therapy programme
    • Results posted

    Objective 1: Assess feasibility and acceptability of all protocol components of a pilot trial testing a 6-week telehealth Mediterranean ketogenic nutrition adherence (KNA) program using motivational interviewing and cognitive…

    Conditions
    Mild Cognitive Impairment, Adherence, Patient, Ketosis
    Trial name
    MI-CBT KNAP (NCT04817176)
    Testing
    Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program, Ketogenic Nutrition Program
    Where
    United States
    Volunteers
    58 people, healthy volunteers welcome
    Sponsor
    Florida State University
    Can I take part? MI-CBT KNAP
  • Mild Cognitive Impairment, Cognitive Impairment

    SNIFF Multi-Device Study 2

    • Completed
    • Age: 55 to 85 years
    • Phase 2
    • Results posted

    The SNIFF Device study will involve using one of three devices to administer insulin through each participant's nose or intra-nasally, accompanied by a lumbar puncture.

    Trial name
    NCT04199767
    Testing
    20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company), 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
    Where
    United States
    Volunteers
    13 people, healthy volunteers welcome
    Sponsor
    Wake Forest University Health Sciences
  • Mild Cognitive Impairment, Cognitive Impairment

    SNIFF - Combo INI+EMPA Trial

    • Completed
    • Age: 55 to 85 years
    • Phase 2
    • Medical device
    • Results posted

    The proposed pilot study will provide safety and efficacy preliminary data regarding singular and combined effects of two therapeutic approaches, intranasal insulin and treatment with the sodium-glucose cotransporter type 2…

    Conditions
    Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease
    Trial name
    NCT05081219
    Testing
    Insulin (Humulin® R U-100), Empagliflozin 10 MG, Aptar Pharma CPS Intranasal Delivery Device
    Where
    United States
    Volunteers
    47 people, healthy volunteers welcome
    Sponsor
    Wake Forest University Health Sciences
  • Mild Cognitive Impairment

    Memory Improvement Through Nicotine Dosing (MIND) Study

    • Completed
    • Age: 55 to 90 years
    • Phase 2
    • Results posted

    The purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI.

    Trial name
    MIND (NCT02720445)
    Testing
    Nicotine Transdermal Patch
    Where
    36 sites in United States
    Volunteers
    348 people
    Sponsor
    University of Southern California
    Can I take part? MIND

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in